This website uses cookies to enhance the user experience.
||
BIOMERIEUX NORGE AS

BIOMERIEUX NORGE AS981 062 310

Purchase and sale
Limited company
Hoffsveien 21 0275 OSLO, Norge

BIOMERIEUX NORGE AS

Operating
bioMérieux | Pioneering Diagnostics
Since 1963, bioMérieux has been paving the way in the field of in vitro diagnostics and has contributed making the world a healthier place.
Produksjon, distribusjon, markedsføring og salg av diagnostika og andre produkter og alt som dermed står i forbindelse, herunder deltagelse i andre selskaper.
Produksjon, distribusjon, markedsføring og salg av diagnostika.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

Chairman of the board
Years since formation
27 years
since Oct 4, 1999
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
2,200
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
74,261,135
NOK
Annual total result 2024
3,086,545
NOK
Total equity 2024
6,365,344
NOK
Last update: Dec 12, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-
Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
A
AZETS INSIGHT AS
Accountant-
Last update: May 14, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
2,200
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
74,261,135
65,015,881
68,575,319
85,661,439
Annual Total Result
3,086,545
4,165,712
4,787,113
6,684,281
Total assets
22,576,569
26,011,578
31,824,020
30,048,657
Total liabilities
16,211,226
22,732,780
24,310,934
16,822,684
Total equity
6,365,344
3,278,798
7,513,086
13,225,973

P&L

Year2024202320222021
Total operating income
74,261,135
65,015,881
68,575,319
85,661,439
Total operating costs
70,703,336
60,115,321
62,646,868
77,127,790
Operating result
3,557,799
4,900,560
5,928,451
8,533,649
Financial income/costs
252,901
443,201
213,574
40,204
Profit before tax
3,810,700
5,343,761
6,142,025
8,573,853
Total tax & extraordinary income/cost
724,155
1,178,049
1,354,912
1,889,572
Annual Total Result
3,086,545
4,165,712
4,787,113
6,684,281

Balance overview

Year2024202320222021
Total fixed assets
4,647,131
2,061,458
570,113
907,471
Total current assets
17,929,438
23,950,120
31,253,907
29,141,186
Total assets
22,576,569
26,011,578
31,824,020
30,048,657
Short term debt
16,211,226
22,732,780
24,310,934
16,822,684
Long term debt
0
0
0
0
Total liabilities
16,211,226
22,732,780
24,310,934
16,822,684
Contributed capital
2,750,000
2,750,000
2,750,000
2,750,000
Retained earnings
3,615,344
528,798
4,763,086
10,475,973
Total equity
6,365,344
3,278,798
7,513,086
13,225,973
Total equity and liabilities
22,576,570
26,011,578
31,824,020
30,048,657

Classification

21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods